Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Current scenario of drug development for leishmaniasis Croft SL; Seifert K; Yardley VIndian J Med Res 2006[Mar]; 123 (3): 399-410Although three new drugs or drug formulations, liposomal amphotericin B (AmBisome), miltefosine and paromomycin should be available for the treatment of visceral leishmaniasis (VL) within the next year, they all suffer from limitations of either cost, specific toxicities or parenteral administration. As part of research to identify better treatments for VL and cutaneous leishmaniasis (CL), alternative and potentially cheaper formulations of amphotericin B, alklyphosphocholines other than miltefosine and improved formulations of paromomycin for CL have been identified. Other drugs or compounds that have demonstrated activity in experimental rodent models of infection include licochalcone derivatives, quinoline derivatives, bisphosphonates and a maesabalide; further chemistry based upon these leads is warranted. The process for discovery and development of new antileishmanials would also benefit from improved models, for example, transfected parasites, and non invasive methods of measuring parasite load in rodent models of infection.|Amphotericin B/*pharmacology[MESH]|Animals[MESH]|Antiprotozoal Agents/*pharmacology[MESH]|Drug Design[MESH]|Humans[MESH]|Leishmania[MESH]|Leishmaniasis, Cutaneous/*drug therapy[MESH]|Leishmaniasis, Visceral/*drug therapy[MESH]|Leishmaniasis/*drug therapy[MESH]|Models, Chemical[MESH]|Paromomycin/*pharmacology[MESH]|Phosphorylcholine/*analogs & derivatives/pharmacology[MESH] |
